Literature DB >> 25476743

What is the role of pharmacogenetics in optimization of warfarin dosing?

Cynthia A Carnes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25476743     DOI： 10.1016/j.tcm.2014.10.003

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN： 1050-1738            Impact factor:   6.677


× No keyword cloud information.
  4 in total

1.  Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.

Authors:  Sylvie Perreault; Payman Shahabi; Robert Côté; Stéphanie Dumas; Étienne Rouleau-Mailloux; Yassamin Feroz Zada; Sylvie Provost; Ian Mongrain; Marc Dorais; Thao Huynh; Simon Kouz; Ariel Diaz; Mark Blostein; Simon de Denus; Jacques Turgeon; Jeffrey Ginsberg; Jacques Lelorier; Lyne Lalonde; Lambert Busque; Jeannine Kassis; Mario Talajic; Jean-Claude Tardif; Marie-Pierre Dubé
Journal:  Clin Cardiol       Date:  2018-05-15       Impact factor: 2.882

2.  Prediction of Warfarin Dose in Pediatric Patients: An Evaluation of the Predictive Performance of Several Models.

Authors:  Elizabeth Marek; Jeremiah D Momper; Ronald N Hines; Cheryl M Takao; Joan C Gill; Vera Pravica; Andrea Gaedigk; Gilbert J Burckart; Kathleen A Neville
Journal:  J Pediatr Pharmacol Ther       Date:  2016 May-Jun

3.  Contrasting Medical and Legal Standards of Evidence: A Precision Medicine Case Study.

Authors:  Gary E Marchant; Kathryn Scheckel; Doug Campos-Outcalt
Journal:  J Law Med Ethics       Date:  2016-03       Impact factor: 1.718

4.  Pharmacogenetics of Anticoagulation and Clinical Events in Warfarin-Treated Patients: A Register-Based Cohort Study with Biobank Data and National Health Registries in Finland.

Authors:  Anna-Leena Vuorinen; Mika Lehto; Mikko Niemi; Kari Harno; Juha Pajula; Mark van Gils; Jaakko Lähteenmäki
Journal:  Clin Epidemiol       Date:  2021-03-08       Impact factor: 4.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.